Shaei Y Huang

Title: The Innovations of Shaei Y Huang

Introduction

Shaei Y Huang is a notable inventor based in Jeffersonville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 4 patents, Huang's work focuses on innovative compounds that target critical pathways in disease management.

Latest Patents

Huang's latest patents include groundbreaking inventions such as inhibitors of checkpoint kinases. This invention provides compounds that comprise substituted triazoloquinazolinones, which inhibit CHK1 activity. The invention also details compositions that include these inhibitory compounds and methods for administering them to patients in need of cancer treatment. Another significant patent involves substituted acylhydroxamic acids, which are designed to reduce TNFα levels and inhibit phosphodiesterase in mammals. A typical embodiment of this invention is (3-(1,3-dioxoisoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propandylamino)propanoate.

Career Highlights

Throughout his career, Huang has worked with prominent companies such as Merck & Company, Inc. and Celgene Corporation. His experience in these leading pharmaceutical firms has allowed him to develop and refine his innovative ideas.

Collaborations

Huang has collaborated with esteemed colleagues, including Hon-Wah Man and George W Muller. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Shaei Y Huang's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving cancer treatment. His work continues to influence the industry and inspire future research.